CAMBRIDGE, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ: CRIS), a drug development company focused on developing the next generation of proprietary targeted medicines for cancer treatment, today announced that the Company will be presenting at the Deutsche Bank 33rd Annual Health Care Conference, which is being held on May 5-7, 2008 in Boston, Massachusetts. Curis’ presentation will take place on Monday, May 5th at 12:00 p.m. Eastern Daylight Time.
